stress ECG
Diagnostic Teststress ECG to patients suspected to be ischemic patients .
NCT Number: NCT05692115
study the ischemic burden in patients with CAE, and its relation to inflammatory markers.
* To assess the ischemic response during exercise ECG among patients with different variants of CAE. * To assess inflammatory biomarkers among patient with different variants of CAE * To assess the relation between the ischemic response and inflammatory markers.
Trial opening soon.
Get Notified18 year–70 year
All sexes
Observational
Coronary artery ectasia (CAE) is a dilation of the coronary artery lumen. The term "ectasia" refers to diffuse dilation of a coronary artery, while focal coronary dilation is called a "coronary aneurysm." The definition of coronary artery ectasia is a dilatation exceeding more than one-third of the coronary artery length with the diameter of the dilated segment measuring more than 1.5 times the diameter of a normal adjacent segment. Coronary artery ectasia is well recognized, but uncommon findings encountered during diagnostic coronary angiography.
inflammation, platelet activation, endothelial dysfunction, microvascular dysfunction, slow flow and vascular remodeling have all been suggested to play a role .
. Available evidence implies that CAE is not a mere variant of CAD; indeed diabetes is negatively associated with CAE and studies pinpoint a critical inflammatory component
Turbulent slow flow within dilated coronaries may lead to platelet activation, thrombosis and eventually acute coronary syndrome Local coronary flow disturbances caused by decreased endothelial shear stress has also been proposed as an alternative explanation for the coexistence of CAD and CAE. Intravascular ultrasound (IVUS) evidence suggests that atherosclerotic plaques within ectatic regions of vessels are highly inflamed and meet high-risk plaque criteria
Mediators of chronic inflammation, such as growth factors and cellular adhesion models, have been widely described in the pathogenesis of CAE. Specifically, the expression of specific inflammatory markers, particularly IL-6 and CRP, is known to be higher in CAE compared with CAD and healthy controls . Most recently, a large meta-analysis elucidated the role of other contributory markers, neutrophil to lymphocyte ratio (NLR) and red cell distribution width (RDW), in the pathogenesis of CAE
Inflammatory markers, C-reactive protein and albumin are believed to be involved in the progression and severity of CAE. Recently, a significantly higher C-reactive protein-to-albumin ratio has been associated with isolated CAE when compared to obstructive CAD and controls. Notably, C-reactive protein-to-albumin ratio also correlated strongly with the severity of CAE, which provides further evidence for its potential role in detection and management
We sought to study the ischemic burden in patients with CAE, and its relation to inflammatory markers.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients with a history of cardiomyopathy or myocardial infarction (MI). Patients with recent acute coronary syndrome Patients with severe renal impairment Post CABG patients Patients with physical incapacity
stress ECG to patients suspected to be ischemic patients .
Time frame: 2 years
Incidence of exercise induced ischemic changes on stress ECG: ST-T changes and chest pain reported by patient.
Time frame: 2 years
Assays of inflammatory markers measured at a fixed time interval among patients as: NLR, RDW, hs-CRP, IL6.
Contact information is provided by the study sponsor or research team.
Kerolos Nageh Nanoush Hakim, Resident
CONTACT
Tarek Abd El Hameed Nagib, Assistant Professor
CONTACT
Assiut University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07511257
Acute Coronary Syndrome, Acute Coronary Syndromes (ACS)
Mexico City, Tlalpan, Mexico
View Trial DetailsNCT05213429
Aneurysm, Cardiovascular Diseases
Amman, Jordan
View Trial DetailsNCT06220682
Aneurysm, Cardiovascular Diseases
Cairo, Egypt
View Trial DetailsNCT05410678
Aneurysm, Cardiovascular Diseases
View Trial Details